| scholarly article | Q13442814 |
| P2093 | author name string | Melanie Zupancic | |
| Misty L Gonzalez | |||
| P2860 | cites work | Direct costs of bipolar disorder versus other chronic conditions: an employer-based health plan analysis. | Q51419274 |
| Is bipolar disorder overdiagnosed among patients with substance abuse? | Q51899625 | ||
| Suicide risk in bipolar patients: the role of co-morbid substance use disorders. | Q51949699 | ||
| Comorbidity of panic disorder in bipolar illness: evidence from the Epidemiologic Catchment Area Survey | Q72492878 | ||
| The National Depressive and Manic-depressive Association (DMDA) survey of bipolar members | Q72879442 | ||
| Consistency of remission and outcome in bipolar and unipolar mood disorders: a 10-year prospective follow-up | Q80440820 | ||
| Challenges and Solutions in Developing New Medications for Schizophrenia | Q82380453 | ||
| Atypical antipsychotics in bipolar disorder: systematic review of randomised trials | Q21260276 | ||
| Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey | Q28258215 | ||
| Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study | Q28259349 | ||
| Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials | Q33975437 | ||
| Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder | Q34183205 | ||
| Comorbidity for obsessive-compulsive disorder in bipolar and unipolar disorders | Q34393749 | ||
| Is bipolar disorder still underdiagnosed? Are antidepressants overutilized? | Q34503731 | ||
| Is lithium still worth using? An update of selected recent research | Q34565672 | ||
| Subthreshold hypomanic symptoms in progression from unipolar major depression to bipolar disorder | Q34589797 | ||
| Overdiagnosis of bipolar disorder among substance use disorder inpatients with mood instability. | Q34599162 | ||
| The evolving epidemiology of bipolar disorder. | Q34722013 | ||
| Aripiprazole for the maintenance treatment of bipolar disorder: a review of available evidence | Q35015469 | ||
| Major depressive disorder with subthreshold bipolarity in the National Comorbidity Survey Replication | Q35132693 | ||
| Clinical consequences of under-recognized bipolar spectrum disorder | Q35592505 | ||
| Maintenance therapies in bipolar disorder: focus on randomized controlled trials | Q36210974 | ||
| Bipolar disorder: disease burden. | Q36227884 | ||
| Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo | Q38394215 | ||
| Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity | Q39921117 | ||
| The epidemiology of bipolar affective disorder | Q40944729 | ||
| Gender and bipolar illness | Q41740628 | ||
| Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study | Q43080173 | ||
| Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study | Q44159999 | ||
| A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania | Q44565868 | ||
| Demographic and clinical characteristics of individuals in a bipolar disorder case registry | Q45027844 | ||
| Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study | Q46178044 | ||
| Cost of treating bipolar disorder in the California Medicaid (Medi-Cal) program | Q46319819 | ||
| Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study | Q46669710 | ||
| Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial | Q46681464 | ||
| Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study | Q46886132 | ||
| Cross-national epidemiology of major depression and bipolar disorder | Q47826731 | ||
| Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study | Q48310435 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 1-6 | |
| P577 | publication date | 2012-01-12 | |
| P1433 | published in | Therapeutics and Clinical Risk Management | Q15766913 |
| P1476 | title | Aripiprazole in the acute and maintenance phase of bipolar I disorder | |
| P478 | volume | 8 |
| Q38244115 | Maintaining mood stability in bipolar disorder: a clinical perspective on pharmacotherapy | cites work | P2860 |
Search more.